JP2008513426A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513426A5
JP2008513426A5 JP2007531830A JP2007531830A JP2008513426A5 JP 2008513426 A5 JP2008513426 A5 JP 2008513426A5 JP 2007531830 A JP2007531830 A JP 2007531830A JP 2007531830 A JP2007531830 A JP 2007531830A JP 2008513426 A5 JP2008513426 A5 JP 2008513426A5
Authority
JP
Japan
Prior art keywords
pharmacology
medicament
inhibition
diseases
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007531830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513426A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2005/003580 external-priority patent/WO2006032851A1/en
Publication of JP2008513426A publication Critical patent/JP2008513426A/ja
Publication of JP2008513426A5 publication Critical patent/JP2008513426A5/ja
Withdrawn legal-status Critical Current

Links

JP2007531830A 2004-09-20 2005-09-19 炎症の治療に有用なピラゾール化合物 Withdrawn JP2008513426A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61095204P 2004-09-20 2004-09-20
US61708104P 2004-10-12 2004-10-12
PCT/GB2005/003580 WO2006032851A1 (en) 2004-09-20 2005-09-19 Pyrazole compounds useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2008513426A JP2008513426A (ja) 2008-05-01
JP2008513426A5 true JP2008513426A5 (enExample) 2008-11-20

Family

ID=35149494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531830A Withdrawn JP2008513426A (ja) 2004-09-20 2005-09-19 炎症の治療に有用なピラゾール化合物

Country Status (4)

Country Link
US (1) US20070225318A1 (enExample)
EP (1) EP1794145A1 (enExample)
JP (1) JP2008513426A (enExample)
WO (1) WO2006032851A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006004027A1 (ja) * 2004-07-01 2008-04-24 第一製薬株式会社 ピラゾール誘導体
US20090076275A1 (en) * 2007-09-19 2009-03-19 David Robert Bolin Diacylglycerol acyltransferase inhibitors
UA103272C2 (uk) 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
US8772345B2 (en) 2011-08-03 2014-07-08 Southwest Research Institute Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
EP2628722A1 (en) * 2012-02-16 2013-08-21 Bayer CropScience AG CF3O-containing enaminoketones and their utilization for the preparation of CF3O-containing pyrazoles
KR102212923B1 (ko) 2012-12-21 2021-02-04 플렉시콘 인코퍼레이티드 키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
CN103012428A (zh) 2013-01-08 2013-04-03 中国药科大学 4-(五元杂环并嘧啶/吡啶取代)氨基-1H-3-吡唑甲酰胺类CDK/Aurora双重抑制剂及其用途
US9162983B2 (en) 2013-05-22 2015-10-20 Southwest Research Institute Reactivators of organophosphorous inhibited acetylcholinesterase
WO2016087593A1 (en) * 2014-12-05 2016-06-09 Syngenta Participations Ag Novel fungicidal quinolinylamidines
EP3997081A1 (en) 2019-07-11 2022-05-18 Escape Bio, Inc. Indazoles and azaindazoles as lrrk2 inhibitors
BR112022021920A2 (pt) 2020-04-29 2023-01-17 Plexxikon Inc Síntese de compostos heterocíclicos
ES3048558A1 (es) * 2024-06-07 2025-12-10 Consejo Superior Investigacion Compuestos inhibidores de sgk1 y su uso para el tratamiento de enfermedades neurodegenerativas y/o cardiovasculares

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US5464860A (en) * 1988-11-30 1995-11-07 Novapharme N(pyrazol-3-yl) benzamides and pharmaceutical compositions
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
ATE195530T1 (de) * 1992-05-20 2000-09-15 Merck & Co Inc 17-ether und thioether von 4-aza-steroiden
CA2135173A1 (en) * 1992-05-20 1993-11-25 Bruce E. Witzel Ester derivatives of 4-aza-steroids
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US6372770B1 (en) * 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
EP0785927B1 (en) 1994-10-12 2003-08-27 Euroceltique S.A. Novel benzoxazoles
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
GB9603095D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
JP3690423B2 (ja) * 1997-03-18 2005-08-31 スミスクライン ビーチャム パブリック リミテッド カンパニー 置換イソキノリン誘導体およびその抗痙攣薬としての使用
AU778393B2 (en) * 1999-05-12 2004-12-02 Ortho-Mcneil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
GB0002666D0 (en) * 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
US6653304B2 (en) * 2000-02-11 2003-11-25 Bristol-Myers Squibb Co. Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
GB0011094D0 (en) * 2000-05-08 2000-06-28 Black James Foundation Gastrin and cholecystokinin receptor ligands (III)
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
JP4465133B2 (ja) * 2001-02-08 2010-05-19 クミアイ化学工業株式会社 イソオキサゾリン誘導体及びこれを有効成分とする除草剤
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
EP1421077A4 (en) 2001-08-31 2004-11-17 Univ Connecticut NEW PYRAZOLANALOGS ON CANNABINOID RECEPTORS
DE60235114D1 (de) * 2001-11-01 2010-03-04 Icagen Inc Pyrazolamide zur anwendung in der behandlung von schmerz
US7016421B2 (en) * 2001-11-15 2006-03-21 Hrl Laboratories, Llc Time-interleaved delta sigma analog to digital modulator
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
WO2004039795A2 (en) * 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
AU2003286876A1 (en) * 2002-11-01 2004-06-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of jak and other protein kinases
US7488158B2 (en) * 2002-11-13 2009-02-10 Deka Products Limited Partnership Fluid transfer using devices with rotatable housings
EP1571671A4 (en) * 2002-12-13 2008-04-02 Matsushita Electric Industrial Co Ltd OPTICAL DATA DISTRIBUTION EQUIPMENT
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
JP2006520373A (ja) * 2003-03-14 2006-09-07 バイオリポックス エービー 炎症の治療に有用なピラゾール化合物
SE0300705D0 (sv) * 2003-03-14 2003-03-14 Biolipox Ab New compounds
US7429603B2 (en) * 2003-04-25 2008-09-30 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
GB0312609D0 (en) * 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
WO2005016877A2 (en) 2003-08-07 2005-02-24 Merck & Co., Inc. Pyrazole carboxamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
EP1794130A1 (en) * 2004-09-20 2007-06-13 Biolipox AB Pyrazole compounds useful in the treatment of inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
JP2009513692A (ja) * 2005-11-01 2009-04-02 バイオリポックス エービー 炎症の治療に有用なピラゾール化合物

Similar Documents

Publication Publication Date Title
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
JP2006502236A5 (enExample)
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
EP2620145A3 (en) 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
JP2003503454A5 (enExample)
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
MX2010001020A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas.
JP2007520565A5 (enExample)
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
JP2008513426A5 (enExample)
JP2008513510A5 (enExample)
JP2003526626A5 (enExample)
JP2004002446A5 (enExample)
JP2006514116A5 (enExample)
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
JP2008513427A5 (enExample)
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas